929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

baricitinib 4 mg tablet, 7

barium sulfate 21 mg/mL oral liquid, 1.9 L

barium sulfate 21 mg/mL oral liquid, 250 mL

barium sulfate 21 mg/mL oral liquid, 450 mL

barium sulfate 2.2% liquid, 2 L

barium sulfate 2.2% liquid, 24 x 450 mL

barium sulfate 2.2% liquid, 250 mL

barium sulfate 2.2% liquid, 36 x 250 mL

barium sulfate 2.2% liquid, 4 x 2 L

barium sulfate 2.2% liquid, 450 mL

barium sulfate 976.5 mg/g powder for oral liquid, 20 kg

barium sulfate 976.5 mg/g powder for oral liquid, 30 x 300 g

barium sulfate 976.5 mg/g powder for oral liquid, 300 g

basiliximab 10 mg injection [1 vial] (&) inert substance diluent [5 mL ampoule], 1 pack

basiliximab 20 mg injection [1 vial] (&) inert substance diluent [5 mL ampoule], 1 pack

conjugated estrogens 450 microgram + bazedoxifene 20 mg modified release tablet, 28

conjugated estrogens 450 microgram + bazedoxifene 20 mg modified release tablet, 7

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 180 actuations

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 2 x 120 actuations

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 3 x 120 actuations

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 60 actuations

beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations

beclometasone dipropionate 100 microgram/actuation inhalation, 100 actuations

beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 2 x 120 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 3 x 120 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 60 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations

beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 2 x 120 actuations

beclometasone dipropionate 50 microgram/actuation inhalation, 100 actuations

beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations

beclometasone dipropionate 50 microgram/actuation nasal spray, 100 actuations

beclometasone dipropionate 50 microgram/actuation nasal spray, 2 x 200 actuations

beclometasone dipropionate 50 microgram/actuation nasal spray, 200 actuations

bedaquiline 100 mg tablet, 188

belatacept 250 mg injection, 1 vial

belimumab 120 mg injection, 1 vial

belimumab 400 mg injection, 1 vial

magnesium trisilicate 50 mg/mL + belladonna tincture 0.05 mL/mL + magnesium carbonate hydrate 50 mg/mL + sodium bicarbonate 50 mg/mL oral liquid, 200 mL

belzutifan 40 mg tablet, 90

bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment, 15 g

bemotrizinol 1% + diethylamino hydroxybenzoyl hexyl benzoate 2.5% + octyl methoxycinnamate 3% + ethylhexyl triazone 0.5% + titanium dioxide 2.9% lotion, 125 mL

bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 125 mL

bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 200 g

bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 50 mL

bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 500 mL

bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 125 mL

bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 250 mL

bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 50 mL

bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 500 mL

bemotrizinol 1.8% + diethylamino hydroxybenzoyl hexyl benzoate 4% + homosalate 8% + octocrylene 8% + titanium dioxide 2.5% lotion, 125 mL

bemotrizinol 1.8% + diethylamino hydroxybenzoyl hexyl benzoate 4% + homosalate 8% + octocrylene 8% + titanium dioxide 2.5% lotion, 250 mL

bendamustine hydrochloride 100 mg injection, 1 vial

bendamustine hydrochloride 25 mg injection, 1 vial

benralizumab 30 mg/mL injection, 1 mL pen device

benralizumab 30 mg/mL injection, 1 mL syringe

levodopa 50 mg + benserazide 12.5 mg capsule, 100

levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100

levodopa 100 mg + benserazide 25 mg capsule, 100

levodopa 100 mg + benserazide 25 mg dispersible tablet, 100

levodopa 100 mg + benserazide 25 mg modified release capsule, 100

levodopa 100 mg + benserazide 25 mg tablet, 100

levodopa 200 mg + benserazide 50 mg capsule, 100

levodopa 200 mg + benserazide 50 mg tablet, 100

bentonite 10% + precipitated sulfur 8% + triclosan 0.1% cream, 18.5 g

bentonite 10% + precipitated sulfur 8% + triclosan 0.1% cream, 20 g

bentonite 10% + precipitated sulfur 8% + triclosan 0.1% cream, 25 g

benzoyl peroxide 5% + bentonite 5% cream, 18.5 g

benzoyl peroxide 5% + bentonite 5% cream, 20 g

benzoyl peroxide 5% + bentonite 5% cream, 25 g

benzalkonium chloride 0.1% + tolnaftate 1% cream, 25 g

benzalkonium chloride 0.1% + ethanol 66% solution, 1 L

benzalkonium chloride 0.1% + ethanol 66% solution, 500 mL

lidocaine hydrochloride monohydrate 2.5% + benzalkonium chloride 0.1% spray, 125 mL

benzalkonium chloride 0.13% lotion, 100 mL

benzalkonium chloride 0.13% lotion, 125 mL

benzalkonium chloride 0.198% spray, 100 mL

choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% gel, 10 g

isopropyl alcohol 76% + benzalkonium chloride 0.13% solution, 1 L

isopropyl alcohol 76% + benzalkonium chloride 0.13% solution, 500 mL

benzalkonium chloride 0.25% + lidocaine hydrochloride 3% + calamine 20% lotion, 125 mL

benzalkonium chloride 2% + light liquid paraffin 65.1% + triclosan 0.7% bath oil, 20 mL

benzalkonium chloride 2% + light liquid paraffin 65.1% + triclosan 0.7% bath oil, 200 mL

benzalkonium chloride 2% + light liquid paraffin 65.1% + triclosan 0.7% bath oil, 250 mL

benzalkonium chloride 2% + light liquid paraffin 65.1% + triclosan 0.7% bath oil, 500 mL

idoxuridine 0.5% + lidocaine hydrochloride 2% + benzalkonium chloride 0.5% cream, 5 g

benzalkonium chloride 0.05% cream, 10 g

benzalkonium chloride 0.05% cream, 100 g

benzalkonium chloride 0.05% cream, 50 g

benzalkonium chloride 6% + light liquid paraffin 52.5% + triclosan 2% bath oil, 150 mL

benzalkonium chloride 6% + light liquid paraffin 52.5% + triclosan 2% bath oil, 25 mL

benzalkonium chloride 6% + light liquid paraffin 52.5% + triclosan 2% bath oil, 350 mL

benzalkonium chloride 6% + light liquid paraffin 52.5% + triclosan 2% bath oil, 500 mL

benzalkonium chloride conditioner, 250 mL

benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, 2 mL cartridge

benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, 10 x 2 mL syringes

benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, 5 x 2 mL syringes

benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes

benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 5 x 2.3 mL syringes

Start Previous Page 24 of 160 Next End

Reference Sets

Reference set descriptor